SCYNEXIS, Inc. (SCYX)

USD 1.09

(12.36%)

Revenue Summary of SCYNEXIS, Inc.

  • SCYNEXIS, Inc.'s latest annual revenue in 2023 was 140.14 Million USD , up 2652.72% from previous year.
  • SCYNEXIS, Inc.'s latest quarterly revenue in 2024 Q1 was 1.37 Million USD , down -76.32% from previous quarter.
  • SCYNEXIS, Inc. reported a annual revenue of 5.09 Million USD in annual revenue 2022, down -61.32% from previous year.
  • SCYNEXIS, Inc. reported a annual revenue of 13.16 Million USD in annual revenue 2021, down 0.0% from previous year.
  • SCYNEXIS, Inc. reported a quarterly revenue of 736 Thousand USD for 2024 Q2, down -46.39% from previous quarter.
  • SCYNEXIS, Inc. reported a quarterly revenue of 131.45 Million USD for 2023 Q2, up 11533.1% from previous quarter.

Annual Revenue Chart of SCYNEXIS, Inc. (2023 - 2012)

Historical Annual Revenue of SCYNEXIS, Inc. (2023 - 2012)

Year Revenue Revenue Growth
2023 140.14 Million USD 2652.72%
2022 5.09 Million USD -61.32%
2021 13.16 Million USD 0.0%
2020 - USD -100.0%
2019 121 Thousand USD -52.92%
2018 257 Thousand USD 0.0%
2017 257 Thousand USD 0.0%
2016 257 Thousand USD 0.0%
2015 257 Thousand USD -79.54%
2014 1.25 Million USD -92.55%
2013 16.85 Million USD 0.12%
2012 16.83 Million USD 0.0%

Peer Revenue Comparison of SCYNEXIS, Inc.

Name Revenue Revenue Difference
Intra-Cellular Therapies, Inc. 464.37 Million USD 69.821%
PainReform Ltd. - USD -Infinity%
Alvotech 91.43 Million USD -53.27%
Collegium Pharmaceutical, Inc. 566.76 Million USD 75.274%
ANI Pharmaceuticals, Inc. 486.81 Million USD 71.213%
Aquestive Therapeutics, Inc. 50.58 Million USD -177.052%
Journey Medical Corporation 79.18 Million USD -76.988%
Dynavax Technologies Corporation 232.28 Million USD 39.668%
Esperion Therapeutics, Inc. 116.33 Million USD -20.464%
Bright Green Corporation 401.49 Thousand USD -34805.141%
Pacira BioSciences, Inc. 674.97 Million USD 79.238%
Embecta Corp. 1.12 Billion USD 87.496%
Sunshine Biopharma, Inc. 24.09 Million USD -481.672%
Sunshine Biopharma, Inc. 24.09 Million USD -481.672%
Petros Pharmaceuticals, Inc. 5.82 Million USD -2306.933%
Silver Spike Investment Corp. 11.72 Million USD -1095.525%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -7166.851%
Alpha Teknova, Inc. 36.68 Million USD -282.022%
Safety Shot Inc 202.67 Thousand USD -69047.382%
Procaps Group, S.A. 409.92 Million USD 65.813%
Cosmos Health Inc. 53.37 Million USD -162.55%
Theratechnologies Inc. 81.76 Million USD -71.397%
Harrow Health, Inc. 130.19 Million USD -7.641%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD -1000.44%
Biofrontera Inc. 34.07 Million USD -311.32%
DURECT Corporation 8.54 Million USD -1539.46%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 76.932%
Cronos Group Inc. 88.84 Million USD -57.744%
OptiNose, Inc. 70.98 Million USD -97.418%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 68.347%
Kala Pharmaceuticals, Inc. - USD -Infinity%
RedHill Biopharma Ltd. 6.51 Million USD -2051.655%
Organogenesis Holdings Inc. 433.14 Million USD 67.645%
Guardion Health Sciences, Inc. 12.24 Million USD -1044.144%
Cumberland Pharmaceuticals Inc. 39.55 Million USD -254.316%
Radius Health, Inc. 2.88 Billion USD 95.138%
Universe Pharmaceuticals INC 32.3 Million USD -333.756%
ProPhase Labs, Inc. 44.38 Million USD -215.747%
Phibro Animal Health Corporation 1.01 Billion USD 86.229%
Procaps Group S.A. 409.92 Million USD 65.813%
TherapeuticsMD, Inc. 1.3 Million USD -10663.518%
Viatris Inc. 15.42 Billion USD 99.092%
Rockwell Medical, Inc. 83.61 Million USD -67.609%
Aytu BioPharma, Inc. 81 Million USD -73.009%
SIGA Technologies, Inc. 139.91 Million USD -0.16%
Tilray Brands, Inc. 788.94 Million USD 82.237%
Lifecore Biomedical, Inc. 128.26 Million USD -9.262%
Shineco, Inc. 9.8 Million USD -1329.739%
PetIQ, Inc. 1.1 Billion USD 87.283%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 12 Thousand USD -1167741.667%
Neurocrine Biosciences, Inc. 1.88 Billion USD 92.574%
Alimera Sciences, Inc. 80.75 Million USD -73.541%
Assertio Holdings, Inc. 152.06 Million USD 7.844%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Clever Leaves Holdings Inc. 17.41 Million USD -704.622%
Cyclo Therapeutics, Inc. 1.07 Million USD -12919.356%
Avadel Pharmaceuticals plc 27.96 Million USD -401.166%
Hempacco Co., Inc. 4.04 Million USD -3364.003%
Talphera, Inc. 651 Thousand USD -21427.035%
Alvotech 91.43 Million USD -53.27%
Eagle Pharmaceuticals, Inc. 316.61 Million USD 55.737%
Lantheus Holdings, Inc. 1.29 Billion USD 89.19%
Currenc Group, Inc. 53.25 Million USD -163.149%
Kamada Ltd. 144.75 Million USD 3.19%
Indivior PLC 1.09 Billion USD 87.178%
Evoke Pharma, Inc. 5.18 Million USD -2605.096%
Flora Growth Corp. 76.07 Million USD -84.224%
Cyclo Therapeutics, Inc. 1.07 Million USD -12919.356%
Evolus, Inc. 202.08 Million USD 30.652%
HUTCHMED (China) Limited 837.99 Million USD 83.277%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 78.252%
Akanda Corp. 2.16 Million USD -6387.853%